0 items USD 0.00Search
Your search for "Machine to Machine (M2M)" gave back 126 results.
There has been incessant rise in prevalence of atrial fibrillation and other heart-related medical conditions such as valvular heart diseases and...
颁补迟补濒辞驳:听
Rockville Research
February 2018
Price: USD 1,050.00
Technological advancement in the global peripheral vascular disease market has led to development of technologies such as novel 鈥�3D鈥� stent system,...
颁补迟补濒辞驳:听
Rockville Research
April 2018
Price: USD 1,100.00
Women鈥檚 Health - Assessing the Need for a Targeted and Specialized Approach Summary Many of the diseases and conditions that affect mainly women are...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2015
Price: USD 2,995.00
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies Summary GBI Research鈥檚...
CBR Pharma Insights
February 2018
Price: USD 2,995.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2018
Price: USD 2,995.00
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research鈥檚 latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 Summary GBI Research鈥檚 latest...
CBR Pharma Insights
June 2017
Price: USD 2,995.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report, 鈥淚nnovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2015
Price: USD 2,995.00
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are...
颁补迟补濒辞驳:听
CBR Pharma Insights
June 2015
Price: USD 2,995.00
Contract Research Organization Market Global Deals and Operational Strategies discusses the deal making activity during the past five years and in-...
颁补迟补濒辞驳:听
CBR Pharma Insights
June 2015
Price: USD 2,995.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 225.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 784.00
This Competitive Intelligence report about Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS provides a competitor evaluation...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 560.00
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016 This Competitive Intelligence report about PD-1 and PD-L1 Immune Checkpoint...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 450.00
听
